相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Reversal of Dabigatran Effects in Models of Thrombin Generation and Hemostasis by Factor VIIa and Prothrombin Complex Concentrate
Maureane Hoffman et al.
ANESTHESIOLOGY (2015)
Role of Oral Anticoagulants in Patients After an Acute Coronary Syndrome
Edward T. Carreras et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Fibrin, γ′-Fibrinogen, and Transclot Pressure Gradient Control Hemostatic Clot Growth During Human Blood Flow Over a Collagen/Tissue Factor Wound
Ryan W. Muthard et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Coagulation Factor Concentrates Fail to Restore Alterations in Fibrin Formation Caused by Rivaroxaban or Dabigatran in Studies With Flowing Blood From Treated Healthy Volunteers
Eduardo Arellano-Rodrigo et al.
TRANSFUSION MEDICINE REVIEWS (2015)
A systems approach to hemostasis: 3. Thrombus consolidation regulates intrathrombus solute transport and local thrombin activity
Timothy J. Stalker et al.
BLOOD (2014)
A systems approach to hemostasis: 2. Computational analysis of molecular transport in the thrombus microenvironment
Maurizio Tomaiuolo et al.
BLOOD (2014)
Thrombosis formation on atherosclerotic lesions and plaque rupture
L. Badimon et al.
JOURNAL OF INTERNAL MEDICINE (2014)
Hierarchical organization in the hemostatic response and its relationship to the platelet-signaling network
Timothy J. Stalker et al.
BLOOD (2013)
Apixaban, an oral, direct factor Xa inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects
Charles Frost et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects
Charles Frost et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Reversal of Apixaban Induced Alterations in Hemostasis by Different Coagulation Factor Concentrates: Significance of Studies In Vitro with Circulating Human Blood
Gines Escolar et al.
PLOS ONE (2013)
Effects of rivaroxaban, acetylsalicylic acid and clopidogrel as monotherapy and in combination in a porcine model of stent thrombosis
E. M. Becker et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
Jessica L. Mega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Venous and arterial thrombosis - pathogenesis and the rationale for anticoagulation
Alexander G. G. Turpie et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome Results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) Trial
John H. Alexander et al.
CIRCULATION (2009)
Relative contributions of collagen and tissue factor to thrombus formation on damaged vascular vessels: in-vitro studies with circulating blood
Irene Lopez-Vilchez et al.
CORONARY ARTERY DISEASE (2009)
Dynamics of platelet thrombus formation
S. P. Jackson et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
The impact of blood rheology on the molecular and cellular events underlying arterial thrombosis
Warwick S. Nesbitt et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2006)
A cell-based model of thrombin generation
HR Roberts et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2006)
BAY 59-7939:: an oral, direct Factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement.: A phase II dose-ranging study
AGG Turpie et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Atherothrombosis and high-risk plaque Part I: Evolving concepts
V Fuster et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
ABC of antithrombotic therapy - Venous thromboembolism: pathophysiology, clinical features, and prevention
AGG Turpie et al.
BMJ-BRITISH MEDICAL JOURNAL (2002)
分享论文
